Pearl River Capital, LLC Dexcom Inc Transaction History

Pearl River Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $190,440 - $274,903	2,241 New	2,241 $253,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $309,354 - $604,649	4,550 New	4,550 $339,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $416,115 - $575,874	-4,423 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $574,415 - $720,152	4,423 New	4,423 $2.38 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $165,594 - $221,853	-2,123 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $202,767 - $239,792	2,123 New	2,123 $875,000
Q2 2020 Aug 10, 2020	SELL	$62.68 - $105.34 $30,775 - $51,721	-491 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$47.79 - $75.63 $23,464 - $37,134	491 New	491 $132,000
Q4 2019 Feb 12, 2020	SELL	$36.62 - $57.29 $109 - $171	-3 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$35.53 - $43.8 $106 - $131	3 New	3 $0
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $35,523 - $49,661	-1,276 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$28.07 - $38.18 $35,817 - $48,717	1,276 New	1,276 $152,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.